We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-3.83%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$723M
AUM Growth
-$101M
Cap. Flow
-$40.9M
Cap. Flow %
-5.66%
Top 10 Hldgs %
78.48%
Holding
32
New
2
Increased
9
Reduced
7
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 79.28%
2 Consumer Staples 0.66%
3 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLDX icon
26
Celldex Therapeutics
CLDX
$3.06B
$324K 0.04%
+1,667
New +$363K
ONCT
27
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$196K 0.03%
189
BLUE
28
DELISTED
bluebird bio
BLUE
-13,814
Closed -$6.9M
GILD icon
29
Gilead Sciences
GILD
$164B
-50,000
Closed -$4.15M
IRWD icon
30
Ironwood Pharmaceuticals
IRWD
$724M
-1,935,361
Closed -$24.8M
TNXP icon
31
Tonix Pharmaceuticals
TNXP
$178M
0
-$1.32M
GTIV
32
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
-601,960
Closed -$9.07M

Similar funds

Oracle Investment Management's Q3 2014 Portfolio in Review

As of Q3 2014, Oracle Investment Management held 32 positions worth $723M, down 12% from $824M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Oracle Investment Management withdrew a net $40.9M in Q3 2014, closing 4 positions and reducing 7 holdings. Its most notable exit was Ironwood Pharmaceuticals, an estimated $24.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 77% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Oracle Investment Management opened a new position in Chimerix, Inc. worth $16.6M.

  • Oracle Investment Management's largest Q3 2014 buy was Chimerix, Inc.: 600,000 shares worth $16.6M.
  • Oracle Investment Management added most to HANSEN MEDICAL, INC. COM NEW in Q3 2014, an estimated $7.84M increase.
  • Oracle Investment Management's biggest Q3 2014 reduction was Tenet Healthcare, cutting an estimated $12M.
  • Oracle Investment Management fully exited Ironwood Pharmaceuticals in Q3 2014, selling an estimated $24.8M.
  • Oracle Investment Management's ten largest holdings make up 78% of its $723M portfolio in Q3 2014.
  • Oracle Investment Management opened 2 new positions and closed 4 in Q3 2014.
  • Oracle Investment Management's portfolio value fell 12% quarter-over-quarter to $723M.

Based on Oracle Investment Management's 13F filing for Q3 2014, filed 14 Nov 2014.